PTMA controls cardiomyocyte proliferation and cardiac repair by enhancing STAT3 acetylation
Science Advances · 23.05.2025 · 11 (21)
DOI: 10.1126/sciadv.adt9446 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, erschienen am 23.05.2025. Verfasst von Ning Liu und 13 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Disease, Chinese Academy of Medical Sciences and P…. Hauptthemen laut MEDLINE: STAT3 Transcription Factor, Myocytes, Cardiac, Thymosin. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
The adult mammalian heart has limited regenerative capacity due to the low proliferative ability of cardiomyocytes, whereas embryonic cardiomyocytes exhibit robust proliferative potential. Using single-cell RNA sequencing of embryonic hearts, we identified prothymosin α (PTMA) as a key factor driving cardiomyocyte proliferation. Overexpression of PTMA in primary mouse and rat cardiomyocytes significantly promoted cardiomyocyte proliferation and similarly enhanced proliferation in human iPSC–derived cardiomyocytes. Conditional knockout of Ptma in cardiomyocytes impaired neonatal heart regeneration. AAV9-mediated overexpression of Ptma extended the neonatal proliferative window and showed therapeutic promise for enhancing adult heart regeneration. Mechanistically, PTMA interacted with MBD3, inhibiting its deacetylation activity within the MBD3/HDAC1 NuRD complex. This inhibition increased STAT3 acetylation, which positively regulated STAT3 phosphorylation and activation of its target genes. These findings establish PTMA as a critical regulator of heart regeneration and suggest its potential as a therapeutic target for ischemic myocardial injury.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Disease, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, China.
- Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Capital Medical University, Beijing 100069, China.
- The First School of Clinical Medicine, Wenzhou Medical University, Wenzhou 325000, China.
- Xi'an International Medical Center, Xi'an 710000, China.
- Department of Cardiology, Nanchong Central Hospital, Nanchong 637000, China.
- National Health Commission Key Laboratory of Cardiovascular Regenerative Medicine, Fuwai Central-China Hospital, Central China Branch of National Center for Cardiovascular Diseases, Zhengzhou 450046, China.
ORCID-Profile: Ning Liu, Jianqiu Pei, Yifan Xie, Xiangjie Li, Zheng Qiao, Yu Nie
Zitieren
APA
Liu, N., Pei, J., Xie, Y., Xuan, H., Jiang, N., Wang, J., Gao, Y., Li, Y., Li, X., Liu, W., Xiang, C., Qiao, Z., Cao, H., & Nie, Y. (2025). PTMA controls cardiomyocyte proliferation and cardiac repair by enhancing STAT3 acetylation. Science Advances, 11(21). https://doi.org/10.1126/sciadv.adt9446
Vancouver
Liu N, Pei J, Xie Y, Xuan H, Jiang N, Wang J, et al. PTMA controls cardiomyocyte proliferation and cardiac repair by enhancing STAT3 acetylation. Science Advances. 2025;11(21). doi:10.1126/sciadv.adt9446
BibTeX
@article{Liu2025,
author = {Liu, Ning and Pei, Jianqiu and Xie, Yifan and Xuan, He and Jiang, Nan and Wang, Jue and Gao, Yangyang and Li, Yixun and Li, Xiangjie and Liu, Weijing and Xiang, Chenying and Qiao, Zheng and Cao, Haiping and Nie, Yu},
title = {PTMA controls cardiomyocyte proliferation and cardiac repair by enhancing STAT3 acetylation},
journal = {Science Advances},
year = {2025},
volume = {11},
number = {21},
doi = {10.1126/sciadv.adt9446}
}
EUVIMED